These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 2809902

  • 1. Effects of two years of methionyl growth hormone therapy in two dosage regimens in prepubertal children with short stature, subnormal growth rate, and normal growth hormone response to secretagogues. (Dutch Growth Hormone Working Group).
    Wit JM, Fokker MH, de Muinck Keizer-Schrama SM, Oostdijk W, Gons M, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJ.
    J Pediatr; 1989 Nov; 115(5 Pt 1):720-5. PubMed ID: 2809902
    [Abstract] [Full Text] [Related]

  • 2. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM, Boersma B, de Muinck Keizer-Schrama SM, Nienhuis HE, Oostdijk W, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJ, Rikken B.
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of two years of growth hormone treatment in short, slowly growing non-growth hormone deficient children.
    Lanes R.
    J Pediatr Endocrinol Metab; 1995 Apr; 8(3):167-71. PubMed ID: 8521190
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: a double-blind, placebo-controlled study.
    Allen DB.
    J Pediatr; 1993 Jan; 122(1):32-6. PubMed ID: 8419612
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Growth hormone therapy with three dosage regimens in children with idiopathic short stature. European Study Group Participating Investigators.
    Rekers-Mombarg LT, Massa GG, Wit JM, Matranga AM, Buckler JM, Butenandt O, Chaussain JL, Frisch H, Leiberman E, Yturriaga R, Aarskog D, Chatelain PG, Colle M, Dacou-Voutetakis C, Delemarre-van de Waal HA, Girard F, Gosen JJ, Irle U, Jansen M, Jean R, Job JC, Kaar ML, Kollemann F, Lenko HL, Waelkens JJ.
    J Pediatr; 1998 Mar; 132(3 Pt 1):455-60. PubMed ID: 9544901
    [Abstract] [Full Text] [Related]

  • 14. Recombinant growth hormone in children and adolescents with Turner syndrome.
    Cave CB, Bryant J, Milne R.
    Cochrane Database Syst Rev; 2003 Mar; (3):CD003887. PubMed ID: 12917993
    [Abstract] [Full Text] [Related]

  • 15. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
    Lampit M, Hochberg Z.
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Contribution of dose and frequency of administration to the therapeutic effect of growth hormone.
    Smith PJ, Hindmarsh PC, Brook CG.
    Arch Dis Child; 1988 May; 63(5):491-4. PubMed ID: 3389862
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.